Literature DB >> 1655673

Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization.

M Polette1, C Clavel, D Muller, J Abecassis, I Binninger, P Birembaut.   

Abstract

The mRNAs encoding 2 metalloproteinases, stromelysin 2 and collagenase I, have been detected by in situ hybridization in 26 carcinomas of the head and neck. 23 tumors of 26 expressed these mRNAs. Collagenase mRNAs were present in individual invasive cancer cells and in tumor cells at the periphery of poorly differentiated clusters (4 cases). Numerous stromal cells, principally fibroblasts were labeled (18 cases). Stromelysin mRNAs have been localized in tumor cells frequently arranged along disrupted basement membranes (8 cases). Many stromal cells in close contact to cancer cells also expressed the stromelysin mRNAs (17 cases). Normal residual cells were never labeled. These observations plead for the role of stromelysin produced by both stromal and tumor cells in the breakdown of basement membranes and the involvement of both collagenase and stromelysin in stromal invasion in carcinomas of the head and neck in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655673

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  19 in total

1.  Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Authors:  J Lu; S Y Chen; H H Chua; Y S Liu; Y T Huang; Y Chang; J Y Chen; T S Sheen; C H Tsai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  The architecture of cancer.

Authors:  J Waxman; H Wasan
Journal:  BMJ       Date:  1992-11-28

3.  Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.

Authors:  N Johansson; K Airola; R Grénman; A L Kariniemi; U Saarialho-Kere; V M Kähäri
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 4.  Matrix metalloproteinase inhibitors: present achievements and future prospects.

Authors:  L J Denis; J Verweij
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 5.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

6.  Topical MMP beacon enabled fluorescence-guided resection of oral carcinoma.

Authors:  Laura Burgess; Juan Chen; Nikolaus E Wolter; Brian Wilson; Gang Zheng
Journal:  Biomed Opt Express       Date:  2016-02-29       Impact factor: 3.732

Review 7.  Role of the extracellular matrix in the degradation of connective tissue.

Authors:  C Mauch; T Krieg; E A Bauer
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.

Authors:  Tomasz Krecicki; Marcin Fraczek; Michal Jelen; Marzena Podhorska; Teresa Szkudlarek; Tomasz Zatonski
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-05-09       Impact factor: 2.503

Review 9.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 10.  Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.

Authors:  P Basset; C Wolf; P Chambon
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.